Lista de obras - Annalisa Pinna - Dominio Público Uruguay

A critical evaluation of behavioral rodent models of motor impairment used for screening of antiparkinsonian activity: The case of adenosine A(2A) receptor antagonists.

artículo científico

A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug

artículo científico publicado en 2009

Acute perinatal asphyxia impairs non-spatial memory and alters motor coordination in adult male rats

artículo científico publicado en 2007

Adenosine A2 receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned rats.

artículo científico publicado en 1994

Adenosine A2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats

artículo científico publicado en 1995

Adenosine A2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas

artículo científico publicado en 1997

Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats

artículo científico publicado en 2003

Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats

artículo científico publicado en 1997

Adenosine A2A receptor antagonists and Parkinson's disease: state of the art and future directions

artículo científico publicado en 2008

Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson's disease

artículo científico publicado en 2007

Adenosine A2A receptor antagonists in Parkinson's disease: progress in clinical trials from the newly approved istradefylline to drugs in early development and those already discontinued

artículo científico

Antidepressants and atypical neuroleptics induce Fos-like immunoreactivity in the central extended amygdala.

artículo científico publicado en 1999

Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease

artículo científico publicado en 2009

Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.

artículo científico publicado en 2008

Behavioral, neurochemical, and electrophysiological changes in an early spontaneous mouse model of nigrostriatal degeneration.

artículo científico publicado en 2010

Blockade of A2A receptors plus l-DOPA after nigrostriatal lesion results in GAD67 mRNA changes different from l-DOPA alone in the rat globus pallidus and substantia nigra reticulata.

artículo científico publicado en 2003

Blockade of A2aAdenosine Receptors Positively Modulates Turning Behaviour and c-Fos Expression Induced by D1Agonists in Dopamine-denervated Rats

artículo científico publicado en 1996

Blockade of muscarinic receptors potentiates D1 dependent turning behavior and c-fos expression in 6-hydroxydopamine-lesioned rats but does not influence D2 mediated responses.

artículo científico publicado en 1993

Blockade ofNMDA receptors differentially affectsD-1 andD-2 mediated turning behavior in the 6-hydroxydopamine model of Parkinson

artículo científico publicado en 1991

C-Fos expression as a molecular marker in corticotropin-releasing factor-induced seizures

artículo científico publicado en 1996

Combined microdialysis and Fos immunohistochemistry for the estimation of dopamine neurotransmission in the rat caudate-putamen

artículo científico publicado en 1992

Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment.

artículo científico publicado en 2005

Differential effect of MK 801 and scopolamine on c-fos expression induced by L-dopa in the striatum of 6-hydroxydopamine lesioned rats

artículo científico publicado en 1994

Differential induction of Fos-like-immunoreactivity in the extended amygdala after haloperidol and clozapine.

artículo científico publicado en 1999

Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated rats.

artículo científico publicado en 2002

Direct and indirect striatal efferent pathways are differentially influenced by low and high dyskinetic drugs: behavioural and biochemical evidence

artículo científico publicado en 2008

Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates L-DOPA-induced rotational behavior in a rodent model of Parkinson's disease

artículo científico publicado en 2015

Dyskinetic potential of dopamine agonists is associated with different striatonigral/striatopallidal zif-268 expression.

artículo científico publicado en 2010

Expression of dyskinetic movements and turning behaviour in subchronic L-DOPA 6-hydroxydopamine-treated rats is influenced by the testing environment.

artículo científico publicado en 2006

How reliable is the behavioural evaluation of dyskinesia in animal models of Parkinson's disease?

artículo científico publicado en 2006

Induction of Fos-like-immunoreactivity in the central extended amygdala by antidepressant drugs

artículo científico publicado en 1999

Interaction between dopamine and adenosine A2A receptors as a basis for the treatment of Parkinson's disease.

artículo científico publicado en 2001

Involvement of adenosine A2A receptors in the induction of c-fos expression by clozapine and haloperidol.

artículo científico publicado en 1999

L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: biochemical and behavioral studies

artículo científico publicado en 2014

L-DOPA-treatment in primates disrupts the expression of A(2A) adenosine-CB(1) cannabinoid-D(2) dopamine receptor heteromers in the caudate nucleus

artículo científico publicado en 2013

Lack of Rhes Increases MDMA-Induced Neuroinflammation and Dopamine Neuron Degeneration: Role of Gender and Age ⬇️

artículo científico

Late-onset Parkinsonism in NFκB/c-Rel-deficient mice

artículo científico publicado en 2012

MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA-pretreated mice

artículo científico publicado en 2013

Modification of adenosine extracellular levels and adenosine A(2A) receptor mRNA by dopamine denervation.

artículo científico publicado en 2002

Neuroprotective potential of adenosine A2A and cannabinoid CB1 receptor antagonists in an animal model of Parkinson disease.

artículo científico publicado en 2014

New adenosine A2A receptor antagonists: actions on Parkinson's disease models

artículo científico publicado en 2005

New therapies for the treatment of Parkinson's disease: adenosine A2A receptor antagonists

artículo científico publicado en 2005

Novel investigational adenosine A2A receptor antagonists for Parkinson's disease.

artículo científico publicado en 2009

Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.

artículo científico publicado en 2011

Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: comparison of the effects of different psychoactive drugs and relevance in drug-induced reward

artículo científico publicado en 2012

Pharmacological therapy of Parkinson's disease: current options and new avenues

artículo científico publicado en 2010

Priming of 6-hydroxydopamine-lesioned rats with L-DOPA or quinpirole results in an increase in dopamine D1 receptor-dependent cyclic AMP production in striatal tissue.

artículo científico publicado en 1997

Role of adenosine A2A receptors in motor control: relevance to Parkinson's disease and dyskinesia

artículo científico publicado en 2018

Role of vesicular dopamine in the in vivo stimulation of striatal dopamine transmission by amphetamine: Evidence from microdialysis and Fos immunohistochemistry

article

Stimulation of dopamine transmission in the dorsal caudate nucleus by pargyline as demonstrated by dopamine and acetylcholine microdialysis and Fos immunohistochemistry.

artículo científico publicado en 1993

Subchronic caffeine exposure induces sensitization to caffeine and cross-sensitization to amphetamine ipsilateral turning behavior independent from dopamine release.

artículo científico publicado en 2003

Subchronic intermittent caffeine administration to unilaterally 6-hydroxydopamine-lesioned rats sensitizes turning behaviour in response to dopamine D(1) but not D(2) receptor agonists.

artículo científico publicado en 2005

Subchronic-intermittent caffeine amplifies the motor effects of amphetamine in rats

artículo científico publicado en 2006

Symptomatic and Neuroprotective Effects of A2A Receptor Antagonists in Parkinson’s Disease

scholarly article published 23 July 2012

The Small GTP-Binding Protein Rhes Influences Nigrostriatal-Dependent Motor Behavior During Aging

artículo científico publicado en 2016

l-Dopa stimulates c-fos expression in dopamine denervated striatum by combined activation of D-1 and D-2 receptors

scientific article published on 01 October 1993

Lista de obras de Annalisa Pinna

A critical evaluation of behavioral rodent models of motor impairment used for screening of antiparkinsonian activity: The case of adenosine A(2A) receptor antagonists.

A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug

Acute perinatal asphyxia impairs non-spatial memory and alters motor coordination in adult male rats

Adenosine A2 receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned rats.

Adenosine A2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats

Adenosine A2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas

Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats

Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats

Adenosine A2A receptor antagonists and Parkinson's disease: state of the art and future directions

Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson's disease

Adenosine A2A receptor antagonists in Parkinson's disease: progress in clinical trials from the newly approved istradefylline to drugs in early development and those already discontinued

Antidepressants and atypical neuroleptics induce Fos-like immunoreactivity in the central extended amygdala.

Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease

Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.

Behavioral, neurochemical, and electrophysiological changes in an early spontaneous mouse model of nigrostriatal degeneration.

Blockade of A2A receptors plus l-DOPA after nigrostriatal lesion results in GAD67 mRNA changes different from l-DOPA alone in the rat globus pallidus and substantia nigra reticulata.

Blockade of A2aAdenosine Receptors Positively Modulates Turning Behaviour and c-Fos Expression Induced by D1Agonists in Dopamine-denervated Rats

Blockade of muscarinic receptors potentiates D1 dependent turning behavior and c-fos expression in 6-hydroxydopamine-lesioned rats but does not influence D2 mediated responses.

Blockade ofNMDA receptors differentially affectsD-1 andD-2 mediated turning behavior in the 6-hydroxydopamine model of Parkinson

C-Fos expression as a molecular marker in corticotropin-releasing factor-induced seizures

Combined microdialysis and Fos immunohistochemistry for the estimation of dopamine neurotransmission in the rat caudate-putamen

Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment.

Differential effect of MK 801 and scopolamine on c-fos expression induced by L-dopa in the striatum of 6-hydroxydopamine lesioned rats

Differential induction of Fos-like-immunoreactivity in the extended amygdala after haloperidol and clozapine.

Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated rats.

Direct and indirect striatal efferent pathways are differentially influenced by low and high dyskinetic drugs: behavioural and biochemical evidence

Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates L-DOPA-induced rotational behavior in a rodent model of Parkinson's disease

Dyskinetic potential of dopamine agonists is associated with different striatonigral/striatopallidal zif-268 expression.

Expression of dyskinetic movements and turning behaviour in subchronic L-DOPA 6-hydroxydopamine-treated rats is influenced by the testing environment.

How reliable is the behavioural evaluation of dyskinesia in animal models of Parkinson's disease?

Induction of Fos-like-immunoreactivity in the central extended amygdala by antidepressant drugs

Interaction between dopamine and adenosine A2A receptors as a basis for the treatment of Parkinson's disease.

Involvement of adenosine A2A receptors in the induction of c-fos expression by clozapine and haloperidol.

L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: biochemical and behavioral studies

L-DOPA-treatment in primates disrupts the expression of A(2A) adenosine-CB(1) cannabinoid-D(2) dopamine receptor heteromers in the caudate nucleus

Lack of Rhes Increases MDMA-Induced Neuroinflammation and Dopamine Neuron Degeneration: Role of Gender and Age ⬇️

Late-onset Parkinsonism in NFκB/c-Rel-deficient mice

MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA-pretreated mice

Modification of adenosine extracellular levels and adenosine A(2A) receptor mRNA by dopamine denervation.

Neuroprotective potential of adenosine A2A and cannabinoid CB1 receptor antagonists in an animal model of Parkinson disease.

New adenosine A2A receptor antagonists: actions on Parkinson's disease models

New therapies for the treatment of Parkinson's disease: adenosine A2A receptor antagonists

Novel investigational adenosine A2A receptor antagonists for Parkinson's disease.

Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.

Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: comparison of the effects of different psychoactive drugs and relevance in drug-induced reward

Pharmacological therapy of Parkinson's disease: current options and new avenues

Priming of 6-hydroxydopamine-lesioned rats with L-DOPA or quinpirole results in an increase in dopamine D1 receptor-dependent cyclic AMP production in striatal tissue.

Role of adenosine A2A receptors in motor control: relevance to Parkinson's disease and dyskinesia

Role of vesicular dopamine in the in vivo stimulation of striatal dopamine transmission by amphetamine: Evidence from microdialysis and Fos immunohistochemistry

Stimulation of dopamine transmission in the dorsal caudate nucleus by pargyline as demonstrated by dopamine and acetylcholine microdialysis and Fos immunohistochemistry.

Subchronic caffeine exposure induces sensitization to caffeine and cross-sensitization to amphetamine ipsilateral turning behavior independent from dopamine release.

Subchronic intermittent caffeine administration to unilaterally 6-hydroxydopamine-lesioned rats sensitizes turning behaviour in response to dopamine D(1) but not D(2) receptor agonists.

Subchronic-intermittent caffeine amplifies the motor effects of amphetamine in rats

Symptomatic and Neuroprotective Effects of A2A Receptor Antagonists in Parkinson’s Disease

The Small GTP-Binding Protein Rhes Influences Nigrostriatal-Dependent Motor Behavior During Aging

l-Dopa stimulates c-fos expression in dopamine denervated striatum by combined activation of D-1 and D-2 receptors